Medicine and Dentistry
Colorectal Cancer
100%
Bevacizumab
100%
Metastatic Colorectal Cancer
66%
Protein-Protein Interaction
50%
Breast Cancer
33%
Combination Therapy
33%
Matrix Metalloproteinase
33%
Interaction Network
33%
Platelet-Derived Growth Factor Subunit A
33%
Malignant Neoplasm
16%
Cancer Therapy
16%
microRNA
16%
Bladder Cancer
16%
Overall Survival
16%
Cell Cycle
16%
Spine
16%
Kinase Signaling
16%
Toll Like Receptor 4
16%
Phosphoinositide 3-Kinase
16%
Cytotoxic Chemotherapy
16%
Clinical Stage
16%
Protein Serine Threonine Kinase
16%
Gene Expression Omnibus
16%
Cyclin Dependent Kinase Inhibitor 1A
16%
Genetic Process
16%
Cytoscape
16%
Signal Transduction
16%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Cancer
100%
Bevacizumab
100%
Metastatic Colorectal Cancer
66%
Breast Cancer
33%
Platelet-Derived Growth Factor Subunit A
33%
Matrix Metalloproteinase
33%
Combination Therapy
33%
Malignant Neoplasm
16%
microRNA
16%
Bladder Cancer
16%
Phosphatidylinositol 3 Kinase
16%
Overall Survival
16%
Toll Like Receptor 4
16%
Protein Serine Threonine Kinase
16%
Cytotoxic Chemotherapy
16%
Cyclin Dependent Kinase Inhibitor 1A
16%
Biochemistry, Genetics and Molecular Biology
Bevacizumab
100%
Protein-Protein Interaction
50%
CD19
33%
Platelet-Derived Growth Factor Subunit A
33%
Matrix Metalloproteinase
33%
Signal Transduction
16%
Gene Expression Omnibus Database
16%
MicroRNA
16%
Threonine
16%
Overall Survival
16%
Cell Cycle
16%
Serine
16%
Gene Ontology
16%
Information Retrieval
16%
Bioinformatics Software
16%
Protein Database
16%
Kinase
16%
Phosphotransferase
16%
Cyclin-Dependent Kinase
16%
Phosphoinositide 3-Kinase
16%
TLR4
16%
Immunology and Microbiology
Bevacizumab
100%
Protein Protein Interaction
50%
CD19
33%
Platelet-Derived Growth Factor Subunit A
33%
Gene Ontology
16%
Gene Expression
16%
Cycline
16%
TLR4
16%
Overall Survival
16%
Spine
16%
Protein Database
16%
Information Retrieval
16%
Bioinformatics Software
16%
Signal Transduction
16%
Cell Cycle
16%
Neuroscience
Bevacizumab
100%
Protein-Protein Interaction
50%
Matrix Metalloproteinase
33%
CD19
33%
Platelet-Derived Growth Factor Subunit A
33%
Gene Expression
16%
MicroRNA
16%
Cell Signaling
16%
Cell Cycle
16%
Phosphoinositide 3-Kinase
16%
TLR 4
16%
Cyclin Dependent Kinase Inhibitor 1A
16%
Protein Serine Threonine Kinase
16%